American Legion throws weight behind marijuana research
AI Overview
Summary is AI-generated, newsroom-reviewed.
The American Legion is urging Congress to reclassify marijuana to allow for medical research, particularly for treating PTSD and TBI among veterans. This follows the DEA's approval of a study on cannabis's effectiveness for PTSD.
Key points from this article:
- The American Legion, representing 2.4 million veterans, passed a resolution advocating for the removal of marijuana from Schedule I at its annual convention.
- How the resolution addresses the needs of thousands of veterans diagnosed with PTSD and TBI from Iraq and Afghanistan, emphasizing the potential benefits of cannabis treatment.
- Why this matters as the DEA has recently approved a study on inhaled marijuana for PTSD, highlighting a shift towards recognizing cannabis's medical value.
The American Legion has called on Congress to remove marijuana from the list of drugs that are classified as having no potential medical use. The Legion, the country’s largest veterans organization with 2.4 million members, passed a resolution at its annual convention last week to promote research on marijuana’s potential use for treating post-traumatic stress […]
What readers are saying
Generating a quick summary of the conversation...
This summary is AI-generated. AI can make mistakes and this summary is not a replacement for reading the comments.








COMMENTS